MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報，我們不為任何個人用途提供產(chǎn)品和服務(wù)。

Solasodine hydrochloride

CAS No. : 6106-33-8

MCE 國際站：Solasodine hydrochloride

產(chǎn)品活性：Solasodine (Purapuridine) hydrochloride 是一種存在于茄科植物中的甾體生物堿。Solaso??dine hydrochloride 通過抑制 p53-MDM2 復(fù)合物、p21Waf1/Cip1 和 Bcl-2 蛋白來誘導(dǎo)細胞凋亡 (apoptosis)。Solaso??dine hydrochloride 具有神經(jīng)保護、抗真菌、降壓、抗癌、抗動脈粥樣硬化、抗雄激素和抗炎活性。

研究領(lǐng)域：Apoptosis??|??Metabolic Enzyme/Protease??|??Anti-infection

作用靶點：MDM-2/p53??|??E1/E2/E3 Enzyme??|??Fungal??|??Apoptosis

In Vitro: Solasodine (90 μM; 2 days) hydrochloride treatment displays significant sprouting in P19 cells. Solasodine hydrochloride induces strong expression of the different neuronal markers studied, including βIII-tubulin, synaptophysin, MAP2, ChAT, and neuroblast marker doublecortin. Solasodine hydrochloride induces the differentiation of P19 cells, essentially towards the neuronal pathway.

In Vivo: Solasodine (25-100?mg/kg; intraperitoneal injection; once) hydrochloride treatment significantly delays latency of hind limb tonic extensor (HLTE) phase in the PCT-induced convulsions. And significantly potentiates Thiopental-provoked sleep in a dose-dependent manner. Solasodine hydrochloride has anticonvulsant and CNS depressant activities.
Solasodine (375 μM; i.c.v.; for 2 weeks) hydrochloride treatment results a significant increase in bromodeoxyuridine uptake by cells of the ependymal layer, subventricular zone, and cortex that co-localized with doublecortin immunostaining. Solasodine hydrochloride treatment in rats results in a dramatic increase in expression of the cholesterol- and drug-binding translocator protein in ependymal cells.

相關(guān)產(chǎn)品：MG-132??|??Ferrostatin-1??|??Rapamycin??|??Cycloheximide??|??Doxorubicin hydrochloride??|??Bafilomycin A1??|??Tamoxifen??|??Y-27632??|??Paclitaxel??|??LY294002??|??Z-VAD-FMK??|??2-Deoxy-D-glucose??|??Acetylcysteine??|??Angiotensin II human??|??Staurosporine??|??Actinomycin D??|??SB-431542??|??5-Fluorouracil??|??Bortezomib??|??Oxaliplatin??|??Deferoxamine mesylate??|??Trametinib??|??Sorafenib??|??Gemcitabine??|??Temozolomide??|??Etoposide??|??Rotenone??|??Decitabine??|??Mdivi-1??|??Monomethyl auristatin E

熱門產(chǎn)品線：重組蛋白? |? 藥物篩選? |? 天然產(chǎn)物? |? 熒光染料? |? PROTAC? |? 同位素標記物

Trending products：Recombinant Proteins? |? Bioactive Screening Libraries? |? Natural Products? |? Dye Reagents? |? PROTAC? |? Isotope-Labeled Compounds

品牌介紹:
????MCE (MedChemExpress) 擁有200 多種全球獨家化合物庫，我們致力于為全球科研客戶提供前沿最全的高品質(zhì)小分子活性化合物；
????50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng)域；
????產(chǎn)品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產(chǎn)品，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目；
????提供虛擬篩選，離子通道篩選，代謝組學(xué)分析檢測分析，藥物篩選等專業(yè)技術(shù)服務(wù)；
????設(shè)有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系；
????提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告，確保產(chǎn)品的高純度、高品質(zhì)；
????產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證；
????Nature, Cell, Science 等多種頂級期刊及制藥專利收錄了MCE客戶的科研成果；
????專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展，為您提供全球最新的活性化合物；
????與世界各大制藥公司及知名科研機構(gòu)建立了長期的合作。